ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.720,01
-1,47%
S&P 500
5.702,55
-0,19%
Dow Jones
42.063,36
0,09%
Euro vs US Dollar
1,11755
0,00%
Bitcoin
63.145,41
-0,09%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Sophia Genetics SA (SOPH)

  7. Sophia Genetics SA (SOPH) News

SOPH

Sophia Genetics (SOPH)

Sophia Genetics SA
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:SOPH
DatumZeitQuelleÜberschriftSymbolFirma
20/09/202403h31Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SOPHSophia Genetics SA
20/09/202403h31Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SOPHSophia Genetics SA
20/09/202403h31Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SOPHSophia Genetics SA
20/09/202403h30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SOPHSophia Genetics SA
20/09/202403h30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SOPHSophia Genetics SA
20/09/202403h30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SOPHSophia Genetics SA
14/09/202415h00PR Newswire (US)SOPHiA GENETICS Presents Ground-Breaking Multimodal Research on AI-Driven Patient Stratification at ESMO 2024NASDAQ:SOPHSophia Genetics SA
13/09/202422h21Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SOPHSophia Genetics SA
12/09/202413h00PR Newswire (US)SOPHiA GENETICS Announces Poster Presentations at ESMO 2024NASDAQ:SOPHSophia Genetics SA
12/09/202410h00PR Newswire (US)SOPHiA GENETICS Announces Updates on SOPHiA UNITY at ESMO 2024NASDAQ:SOPHSophia Genetics SA
12/09/202410h00PR Newswire (US)SOPHiA GENETICS Announces Updates on SOPHiA UNITY at ESMO 2024NASDAQ:SOPHSophia Genetics SA
10/09/202416h28PR Newswire (US)SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy TestingNASDAQ:SOPHSophia Genetics SA
10/09/202416h16PR Newswire (US)SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy TestingNASDAQ:SOPHSophia Genetics SA
05/09/202414h30PR Newswire (US)SOPHiA GENETICS Announces Validation of Novel Clinical Trial Assay Together with Precision for Medicine at World Clinical Biomarkers & CDx 2024NASDAQ:SOPHSophia Genetics SA
04/09/202412h00PR Newswire (US)SOPHiA GENETICS Unveils New Generation of the SOPHiA DDMTM Platform at Morgan Stanley Healthcare Conference 2024NASDAQ:SOPHSophia Genetics SA
28/08/202419h30PR Newswire (US)SOPHiA GENETICS to Present at the 22nd Annual Morgan Stanley Healthcare Conference and 9th Annual TD Cowen FutureHealth ConferenceNASDAQ:SOPHSophia Genetics SA
20/08/202403h07Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SOPHSophia Genetics SA
20/08/202403h07Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SOPHSophia Genetics SA
20/08/202403h06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SOPHSophia Genetics SA
20/08/202403h06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SOPHSophia Genetics SA
20/08/202403h06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SOPHSophia Genetics SA
20/08/202403h06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SOPHSophia Genetics SA
14/08/202409h00PR Newswire (US)SOPHiA DDM™ Platform Certified Under IVDRNASDAQ:SOPHSophia Genetics SA
14/08/202409h00PR Newswire (US)SOPHiA DDM™ Platform Certified Under IVDRNASDAQ:SOPHSophia Genetics SA
06/08/202413h08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SOPHSophia Genetics SA
06/08/202412h45PR Newswire (US)SOPHiA GENETICS Reports Second Quarter 2024 ResultsNASDAQ:SOPHSophia Genetics SA
29/07/202416h30PR Newswire (US)SOPHiA GENETICS Announces L'hôpital Universitaire Avicenne is Live on SOPHiA DDM™NASDAQ:SOPHSophia Genetics SA
29/07/202416h30PR Newswire (US)SOPHiA GENETICS Announces L'hôpital Universitaire Avicenne is Live on SOPHiA DDM™NASDAQ:SOPHSophia Genetics SA
25/07/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SOPHSophia Genetics SA
24/07/202417h59PR Newswire (US)SOPHIA GENETICS Announces Expanded Relationship with Canada-Based OncoHelixNASDAQ:SOPHSophia Genetics SA
 Showing the most relevant articles for your search:NASDAQ:SOPH

Kürzlich von Ihnen besucht

BIT
F13078
Vontobel Financial Produ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten